This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Ciba-Geigy Corporation, Gesellschaft Fur Biotechnologische Forschung Mbh, Helmholtz-Zentrum Fur Infektionsforschung Gmbh. Active years: 1997-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brunswick, DE (1997)
- Braunschweig, DE (1997 - 2011)
- Braunschweig/Leiferde, DE (2012)
Company Filing History:
3 out of 6,858 
3 out of 21 
2 out of 28 
Years Active: 1997-2012
Title: The Innovations of Florenz Sasse
Introduction
Florenz Sasse is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of compounds with therapeutic applications. With a total of eight patents to his name, Sasse's work has the potential to impact the treatment of various proliferative diseases.
Latest Patents
One of Sasse's latest patents focuses on the use of inhibitors of the degradation of p27, specifically Argyrin and its derivatives, for the treatment of proliferative diseases such as cancer. This invention highlights the potential of macrocycles as inhibitors of proteasomic degradation, offering new avenues for cancer treatment. Another recent patent involves a novel group of compounds with antibiotic, antifungal, and cytostatic properties, derived from myxobacteria. This group includes compounds such as Disorazole Z and Disorazole Z-epoxide, which exhibit specific substituents and unsaturated bonds in their cyclic core structure.
Career Highlights
Throughout his career, Florenz Sasse has worked with prominent organizations, including Ciba-Geigy Corporation and Gesellschaft für Biotechnologische Forschung mbH. His experience in these companies has contributed to his expertise in biotechnology and innovation.
Collaborations
Sasse has collaborated with notable colleagues, including Heinrich Steinmetz and Hans Reichenbach. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Florenz Sasse's contributions to biotechnology through his patents and collaborations demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments and innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile